Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WAIR
2226
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $2.44M | ﹤0.01% |
219,710
+95,610
| +77% | +$917K |
|
|
HIMX
2227
Himax Technologies
HIMX
$2.56B
| $2.43M | ﹤0.01% |
698,361
-705,903
| -50% | -$2.33M |
|
|
ILPT
2228
Industrial Logistics Properties Trust
ILPT
$611M
| $2.43M | ﹤0.01% |
116,566
+86,954
| +294% | +$1.73M |
|
2229
Cato Corp
CATO
$65.7M
| $2.42M | ﹤0.01% |
196,550
-159,251
| -45% | -$2.17M |
|
|
VNTR
2230
DELISTED
Venator Materials PLC
VNTR
| $2.42M | ﹤0.01% |
457,200
+292,300
| +177% | +$1.6M |
|
2231
Tempest Therapeutics
TPST
$18.7M
| $2.41M | ﹤0.01% |
1,071
+536
| +100% | +$1.58M |
|
|
PFSW
2232
DELISTED
PFSweb, Inc.
PFSW
| $2.4M | ﹤0.01% |
593,839
+12,200
| +2% | +$52.4K |
|
2233
Under Armour
UAA
$2.3B
| $2.4M | ﹤0.01% |
94,800
-346,900
| -79% | -$8.13M |
|
2234
Hormel Foods
HRL
$13.4B
| $2.4M | ﹤0.01% |
59,200
-323,200
| -85% | -$13.1M |
|
|
GNC
2235
DELISTED
GNC Holdings, Inc.
GNC
| $2.39M | ﹤0.01% |
1,595,199
+941,200
| +144% | +$1.78M |
|
2236
ePlus
PLUS
$2.31B
| $2.39M | ﹤0.01% |
69,400
+43,600
| +169% | +$1.81M |
|
2237
SFL Corp
SFL
$1.57B
| $2.39M | ﹤0.01% |
191,032
+91,500
| +92% | +$1.16M |
|
|
GNTY
2238
DELISTED
Guaranty Bancshares
GNTY
| $2.38M | ﹤0.01% |
84,070
+13,530
| +19% | +$356K |
|
2239
Hallador Energy
HNRG
$730M
| $2.38M | ﹤0.01% |
422,292
+46,392
| +12% | +$250K |
|
2240
Dorian LPG
LPG
$1.91B
| $2.37M | ﹤0.01% |
262,400
+223,663
| +577% | +$1.78M |
|
2241
NCR Voyix
VYX
$1.17B
| $2.36M | ﹤0.01% |
123,717
-503,018
| -80% | -$9.35M |
|
2242
NNN REIT
NNN
$8.87B
| $2.36M | ﹤0.01% |
44,500
-125,400
| -74% | -$6.7M |
|
2243
Global Water Resources
GWRS
$256M
| $2.35M | ﹤0.01% |
224,663
+8,538
| +4% | +$83.8K |
|
2244
Mitek Systems
MITK
$853M
| $2.34M | ﹤0.01% |
235,576
+218,507
| +1,280% | +$2.33M |
|
2245
BorgWarner
BWA
$14B
| $2.34M | ﹤0.01% |
63,267
-147,802
| -70% | -$5.24M |
|
2246
Weyco Group
WEYS
$446M
| $2.34M | ﹤0.01% |
87,500
-4,500
| -5% | -$134K |
|
|
IVAC
2247
DELISTED
Intevac Inc
IVAC
| $2.34M | ﹤0.01% |
482,692
+38,684
| +9% | +$202K |
|
2248
Nordic American Tanker
NAT
$1.4B
| $2.33M | ﹤0.01% |
997,500
+593,500
| +147% | +$1.28M |
|
2249
Keurig Dr Pepper
KDP
$42.3B
| $2.33M | ﹤0.01% |
+80,700
| New | +$2.3M |
|
2250
Ternium
TX
$10.8B
| $2.33M | ﹤0.01% |
103,900
+34,200
| +49% | +$855K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.